ADIL Adial Pharmaceuticals
- 1.0900
- +0.0295+2.78%
Adial Pharmaceuticals News
Adial Pharmaceuticals' New Purchase Agreement With Alumni Capital
Express News | Adial Pharmaceuticals Inc - Can Sell up to $10 Million in Shares
Express News | Adial Pharmaceuticals Inc - on Dec 13, Enters Purchase Agreement With Alumni Capital
Adial Pharmaceuticals Extends CEO Cary Claiborne's Tenure
EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations
Express News | EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga Co. Granted Key U.S. Patent For The Treatment Of Alcohol And Drug Dependence Based On Expanded Genotype Combinations
Adial Pharmaceuticals (ADIL) Upgraded to Buy: Here's What You Should Know
Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating
Maxim Group Sticks to Their Hold Rating for Adial Pharmaceuticals (ADIL)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Express News | Adial Pharmaceuticals : Continued Excellent Safety & Tolerability Findings, Consistent With Extensive Human Use Experience With Ondansetron
Express News | Adial Pharmaceuticals Inc - Study Completion Satisfies FDA Requirement for Phase 3 Trials
Adial Pharmaceuticals Announces Positive Topline Results From the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder
Express News | EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga 'Marks Final Study Needed for the Upcoming FDA Meeting for the Phase 3 Study Design and Ongoing Partnership Discussions'
Express News | EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga 'Confirmed Relative Bioavailability to the Reference Standard, Dose Proportional Increases in Pharmacokinetic Exposure, and No Food Effect'
Express News | EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga Co. Announces Results From AD04-103 Pharmacokinetics Study Of AD04 For The Treatment Of Alcohol USE Disorder
This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Adial Pharmaceuticals Analyst Ratings
Adial Pharmaceuticals Initiated With a Buy at Rodman & Renshaw
No Data